ReqMed to survey Japanese pharma research

22 July 2001

US start-up biotechnology company ReqMed has set up an operation inTokyo, Japan, to survey pharmaceutical research within the country's university laboratories and other organizations, and assess the likelihood of commercial developments, reports the Nikkei Weekly. Where appropriate, ReqMed also plans to apply for US patents on any suitable products and license these out to pharmaceutical companies.

ReqMed's first foray into Japanese research will focus on efficient methods for the discovery of compounds that can influence the functioning of proteins related to various diseases, the Nikkei notes.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight